Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell G Buhr

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Annals of the American Thoracic Society|April 8, 2025
Characteristics Associated with Lung Function Trajectories: An Analysis of the SPIROMICS CohortRussell G Buhr, Nicholas J Jackson, Jane C Fazio, et al.
Annals of the American Thoracic Society|March 11, 2025
Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS CohortIgor Barjaktarevic, Roxana Hixson, Zian Zhuang, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2024
The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort StudyRajat Suri, Daniela Markovic, Han Woo, et al.
American Journal of Respiratory and Critical Care Medicine|November 25, 2024
Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research StatementYet H Khor, Vitalii Poberezhets, Russell G Buhr, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 3, 2022
Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS CohortBonnie E Ronish, David J Couper, Igor Z Barjaktarevic, et al.
Chest|February 4, 2021
Ratio of FEV<sub>1</sub>/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung FunctionSpyridon Fortis, Alejandro P Comellas, Surya P Bhatt, et al.
JAMA Network Open|July 16, 2025
Self-Reported Resilience During the COVID-19 PandemicOluwabunmi Ogungbe, Tianyou Wang, Pallavi P Balte, et al.
The New England Journal of Medicine|September 6, 2022
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung FunctionMeiLan K Han, Wen Ye, Di Wang, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort AnalysisIgor Z Barjaktarevic, Russell G Buhr, Xiaoyan Wang, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Annals of the American Thoracic Society|April 8, 2025
Characteristics Associated with Lung Function Trajectories: An Analysis of the SPIROMICS CohortRussell G Buhr, Nicholas J Jackson, Jane C Fazio, et al.
Annals of the American Thoracic Society|March 11, 2025
Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS CohortIgor Barjaktarevic, Roxana Hixson, Zian Zhuang, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2024
The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort StudyRajat Suri, Daniela Markovic, Han Woo, et al.
American Journal of Respiratory and Critical Care Medicine|November 25, 2024
Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research StatementYet H Khor, Vitalii Poberezhets, Russell G Buhr, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 3, 2022
Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS CohortBonnie E Ronish, David J Couper, Igor Z Barjaktarevic, et al.
Chest|February 4, 2021
Ratio of FEV<sub>1</sub>/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung FunctionSpyridon Fortis, Alejandro P Comellas, Surya P Bhatt, et al.
JAMA Network Open|July 16, 2025
Self-Reported Resilience During the COVID-19 PandemicOluwabunmi Ogungbe, Tianyou Wang, Pallavi P Balte, et al.
The New England Journal of Medicine|September 6, 2022
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung FunctionMeiLan K Han, Wen Ye, Di Wang, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort AnalysisIgor Z Barjaktarevic, Russell G Buhr, Xiaoyan Wang, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Changes in Lung Volumes with Spirometric Disease Progression in COPDMehrdad Arjomandi, Siyang Zeng, Jianhong Chen, et al.
Pageof 6